Experimental Malaria Vaccine Being Tested In Kenya, Showing Good Results

VOA News: New Malaria Vaccine Shows Promise in Kenya
“…[S]cientists in Kenya say that next year, a new malaria vaccine will be available that could add an important component to malaria control and potentially eradicate the disease. … Although existing interventions have helped to reduce the disease over the past decade, scientists in this lab in western Kenya are working on a vaccine — with the help of Britain’s GlaxoSmithKline and other partners — that could add an important component to malaria control…” (Yusuf, 11/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.